T1	Intervention 14 32	placebo-controlled
T2	Intervention 50 74	ganitumab or conatumumab
T3	Intervention 278 289	bevacizumab
T4	Intervention 294 306	aflibercept.
T5	Intervention 347 358	conatumumab
T6	Intervention 429 438	ganitumab
T7	Intervention 734 786	fluoropyrimidine- and oxaliplatin-based chemotherapy
T8	Intervention 824 917	intravenous FOLFIRI plus conatumumab 10 mg/kg (Arm A), ganitumab 12 mg/kg (Arm B), or placebo
T9	Intervention 1453 1476	CONCLUSIONS Conatumumab
T10	Intervention 1482 1509	not ganitumab, plus FOLFIRI
